AIM: To investigate the changes of neuropeptide Y (NPY) level in one-kidney one-clip (1k1c) renovascular hypertensive rats. METHODS: The experiment was conducted in the Laboratory of Geriatric Disease, General Hospital of Chinese PLA from August to December 2003. Twenty-one healthy male Wistar rats were randomly divided into 3 groups with 7 rats in each group: control group, hypertensive group and spironolactone group.①Intervention respectively: The rats in the control group received a sham operation and 10 g/L saline for 14-day drinking. The rats in the hypertensive group were treated with a 1k1c operation (Left-side renal artery was clamped with a 0.2-mm-diameter clip applying forceps, and the kidney in the right side was removed) to establish renovascular hypertensive models, 10 g/L saline was given for 14-day drinking. Rats in the spironolactone group received modeling the same as hypertensive group and intragastric perfusion of 20mg/kg spironolactone per day for 14 continuous days.②Fourteen days later, the mean arterial pressure (MAP) of rats was measured via the arteria caudilis, and heart tissue was weighted and the ratio of left ventricular mass (LVM)/ body weight (BW) was calculated.③Levels of aldosterone, angiotensin Ⅱ and NPY in plasma were determined with radio-immunoassay. RESULTS: A total of 21 rats were involved in the analysis of results.①Level of MAP in rats: It was significantly higher in the hypertensive group and spironolactone group than that in the control group (187.14±28.56),(159.29±27.75), (127.14±8.59) mm Hg,1 mm Hg=0.133 kPa, P 0.05.②The ratio of LVM/BW: it was significantly lower in the spironolactone group than that in the hypertensive group (2.36±0.31), (3.02±0.64), P 0.05.③The level of aldosterone in plasma: it was significantly higher in spironolactone group than that in the hypertensive group (1.33±0.83),(0.54±0.26) ng/L,P 0.05.④The level of NPY in plasma: it was remarkably increased in the spironolactone group than that in the hypertensive group (48 222±33 217), (5 375±2 916) ng/L, P 0.05. CONCLUSION: Endogenous aldosterone can negatively control the secretion of NPY by binding with its receptor.